The results of this call for evidence will inform the development of the next 5-year national action plan (NAP) on antimicrobial resistance (AMR), which will run from 2024 to 2029. The 2024 to 2029 NAP will continue being developed in consultation with a broad range of stakeholders across different sectors. It will build on the achievements of the 2019 to 2024 NAP, while…
Ben KempAugust 18, 2023